CDC42 Rho GTPase inhibitors (University of New Mexico/Science & Technology Corporation @ UNM)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCDC42 Rho GTPase inhibitors (University of New Mexico/Science & Technology Corporation @ UNM)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division control protein 42 homolog inhibitors
TargetsCell division control protein 42 homolog
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of New Mexico
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStc.UnmThe University Of New Mexico
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A